QID 240108

Date Published: 2022-02-28

QID 240108: Red Hat Update for ruby:2.5 (RHSA-2022:0672)

ruby is an extensible, interpreted, object-oriented, scripting language.
It has features to process text files and to perform system management tasks.

Security Fix(es):
  • rubygem-rdoc: command injection vulnerability in rdoc (cve-2021-31799)
  • ruby: ftp pasv command response can cause net::ftp to connect to arbitrary host (cve-2021-31810)
  • ruby: starttls stripping vulnerability in net::imap (cve-2021-32066)

Affected Products:

  • Red Hat enterprise linux for x86_64 8 x86_64
  • Red Hat enterprise linux for ibm z systems 8 s390x
  • Red Hat enterprise linux for power, little endian 8 ppc64le
  • Red Hat enterprise linux for arm 64 8 aarch64



Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as High - 7.4 severity.
  • CVSS V2 rated as Medium - 5.8 severity.
    • Solution
    Refer to Red Hat security advisory RHSA-2022:0672 for updates and patch information.
    Vendor References

    CVEs related to QID 240108

    CVE-2021-31799 | CVE-2021-31810 | CVE-2021-32066 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2022:0672 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2022:0672
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].